← FDA Drug Approvals (Drugs@FDA)

OTEZLA

NDA · New Drug Application · Sponsor: CELGENE CORP · Approved 2014-09-23

Drug application

FDA Application #

NDA206088

Application type

New Drug Application

Brand name

OTEZLA

Generic name

Apremilast

Active ingredients

APREMILAST

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CELGENE CORP

First approval

2014-09-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown